" class="no-js "lang="en-US"> Fluent BioSciences - Medtech Alert
Thursday, July 31, 2025
Fluent BioSciences | Pharmtech Focus

Fluent BioSciences

About Fluent BioSciences

Fluent BioSciences

Fluent BioSciences is a privately funded biotechnology company with a mission to accelerate the understanding of biology and disease through simple, cost effective and scalable solutions for every laboratory from research to the clinic.

Fluent’s breakthrough Pre-templated Instant Partitions (PIPseq™) technology enables near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. This powerful platform enables extremely sensitive and unbiased preparation of proteins and nucleic acids for a broad range of discovery and disease applications including single-cell RNA sequencing (scRNA-Seq).

Related Story

Fluent Biosciences Launches Industry's First Single Tube 100,000 Cell Product to Enable Unprecedented Scale, Cost-efficiency and Access for Single-cell RNA Sequencing

September 28 2022

Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to […]

Fluent BioSciences Launches Industry's Most Accessible, Cost-effective and Scalable Technology (PIPseqTM) to Accelerate Adoption of Single-cell RNA Sequencing in Any Laboratory

June 24 2022

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]

Fluent BioSciences and NanoCellect Announce Joint Collaboration to Improve Resolution of Single-cell RNA Sequencing Analysis of Rare Cell Populations

June 20 2022

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]